| Product |
CAS |
Molecular formula |
More |
| (5Z,8z,11z,14z)-n-(2-fluoroethyl)-2-methyl-5,8,11,14-icosatetraenamide |
166100-39-6 |
C23H38FNO |
More |
| 16,16-Dimethyl prostaglandin e1 |
41692-15-3 |
C22H38O5 |
More |
| (3-{[(4-Fluorophenyl)sulfonyl](methyl)amino}-1,2,3,4-tetrahydro-9h-car |
627865-18-3 |
C21H21FN2O4S |
More |
| (5Z,8xi,13e)-9,15-dihydroxy-n-(2-hydroxyethyl)-11-oxoprosta-5,13-dien- |
398138-28-8 |
C22H37NO5 |
More |
| (5Z,8beta,9beta,11beta,12alpha,13e,15r)-9,11,15-trihydroxyprosta-5,13- |
54483-31-7 |
C20H34O5 |
More |
| (2-Mercaptoethyl)-guanidine sulfate |
3979-00-8 |
C6H20N6O4S3 |
More |
| 3-Methoxymethcathinone hydrochloride |
1435933-70-2 |
C11H16ClNO2 |
More |
| (4Z,7e,9e,13z,16z,19z)-11-hydroxy-4,7,9,13,16,19-docosahexaenoic acid |
87018-59-5 |
C22H32O3 |
More |
| N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)undecanamide |
869376-63-6 |
C25H41NO3 |
More |
| (13E,15r)-15-hydroxy-9-oxo-prosta-10,13-dien-1-oicacid |
20897-92-1 |
C21H32O5 |
More |
| 2,3-Dihydroxypropyl (5z,8xi,13e)-9,15-dihydroxy-11-oxoprosta-5,13-dien |
309260-52-4 |
C23H38O7 |
More |
| (4Z,7z,10z,13z,17z,19z)-16-hydroxy-4,7,10,13,17,19-docosahexaenoic aci |
90780-51-1 |
C22H32O3 |
More |
| (5Z,8r,9e,11z,14z)-8-hydroxy-5,9,11,14-icosatetraenoic acid |
105500-09-2 |
C20H32O3 |
More |
| (2-Methyl-4-oxopyran-3-yl) 2-acetyloxybenzoate |
147249-33-0 |
C15H12O6 |
More |
| {(1R,2s)-3-oxo-2-[(2z)-2-penten-1-yl]cyclopentyl}acetic acid |
62653-85-4 |
C12H18O3 |
More |
| (5Z,13e,15r)-15-hydroxy-15-methyl-9-oxoprosta-5,10,13-trien-1-oic acid |
96440-68-5 |
C21H32O4 |
More |
| 2-Arachidonyl glycerol ether |
222723-55-9 |
C23H40O3 |
More |
| (5E,8e,12e,14e,17e)-11-hydroxy-5,8,12,14,17-icosapentaenoic acid |
99217-78-4 |
C20H30O3 |
More |
| 7-Methyl-6-thioguanosine |
55727-10-1 |
C11H15N5O4S |
More |
| 1-(3-Cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid mo |
35607-36-4 |
C28H29ClN2O2 |
More |
|